Peking University First Hospital — Beijing

Public research footprint of Peking University First Hospital, compiled from the ClinicalTrials.gov public registry.

999

Registered studies

437

Active

257

Recruiting now

361

Completed

Stopped or withdrawn

Most-studied conditions

Acute Myeloid Leukemia (AML) Relapse · Diffuse Large B-cell Lymphoma · Primary Membranous Nephropathy · Follicular Lymphoma (FL)

Recently updated registry entries

NCT06895538 — Comparison of ATLG and ATG for Immune Reconstitution After Allo-HSCT for Hematologic… (Recruiting)
NCT06935357 — A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin… (Recruiting)
NCT06081894 — A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Peking University First Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.